Manufacturing Execution System (MES) that digitally guides and records batch procedures for pharmaceutical manufacturing with FDA 21 CFR Part 11 compliance.
Aspen Production Execution Manager is a Manufacturing Execution System (MES) for pharmaceutical batch manufacturing. It digitally guides and records batch procedures, aligned with the ISPE Pharma 4.0 initiative, and automates, guides and digitally records SOPs according to cGMP guidelines. It automatically generates audit trails and electronic records in compliance with FDA 21 CFR Part 11, and monitors, manages and synchronises production processes in real time, with compliance built into the system design. AspenTech states that the system reduces human error and minimises deviation risk, provides compliance, control, transparency and traceability, and increases production quality while reducing cycle time, cost and waste.
Part of AspenTech's broader industrial software portfolio. AspenTech now wholly owned by Emerson following 2022 combination (55% stake for $6B) and 2025 full acquisition ($7.2B for remaining 43%). Company serves pharmaceutical sector alongside chemicals, oil & gas, and other asset-intensive industries.
Pharmaceutical Edition
Pharma-specific MES edition for pharmaceutical manufacturing, aligned with the ISPE Pharma 4.0 initiative. It includes batch execution digitalisation, cGMP-compliant SOP automation, and electronic batch records, and complies with FDA 21 CFR Part 11 and EU Annex 11. AspenTech states the system reduces error and risk and boosts efficiency. GlaxoSmithKline used the MES technology to speed up batch release time.
Core Capabilities
FDA & GxP Compliance
International Standards
Data Integrity & Validation
MES platform designed for pharmaceutical batch manufacturing environments. Provides real-time monitoring and synchronization of production processes with compliance built into system design. Integrates with industrial automation systems and enterprise software for pharmaceutical manufacturing. Part of broader AspenOne industrial software portfolio spanning process optimization, supply chain, and manufacturing execution.
Deployment options are undisclosed. API and integration capabilities connect to ERP systems, quality systems, and other enterprise applications common in pharmaceutical manufacturing.
Pricing is not publicly disclosed. Contact with sales is required for pricing information.
AspenTech is wholly owned by Emerson, following a 2025 full acquisition for $7.2B and a 2022 combination. The product is part of the broader AspenOne software portfolio, sold to pharmaceutical, chemical, oil and gas, and other asset-intensive industries. Demo and evaluation availability through sales contact is undisclosed.
Implementation timeline and services are undisclosed.
GlaxoSmithKline implemented the MES technology to speed up batch release time. AspenTech provides implementation and professional services as part of its broader industrial software portfolio. Whether validation support is included is undisclosed.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Strengths
Named pharmaceutical customer GlaxoSmithKline achieved faster batch release time using AspenTech MES technology. The solution aligns with the ISPE Pharma 4.0 digitalisation initiative. Built-in compliance with FDA 21 CFR Part 11 and EU Annex 11 reduces validation burden. Automatic audit trail generation and electronic signatures support regulatory requirements. Digital batch execution reduces human error and deviation risk.
Limitations & Open Questions
Pricing is not publicly disclosed and requires sales contact for evaluation. Implementation timelines and validation documentation are largely undisclosed. GlaxoSmithKline is the only publicly named pharmaceutical customer, which limits ability to assess market penetration. Review platform presence is minimal. The product is part of the broader AspenOne industrial software portfolio, which may require broader platform investment.
Help the community
Share your experience with Aspen Production Execution Manager anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section